Caresyntax
PrivateLast Round
Debt
Aug 15, 2024
Total Funding Raised
$325M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Caresyntax operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Debt round in August 2024.
Caresyntax is a healthcare technology company that provides a vendor-neutral, AI-powered surgical intelligence platform designed to improve patient outcomes and operational efficiency in operating rooms.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Medical AI, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service, Services & Consulting, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Caresyntax Comparables
Compare Caresyntax with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Surgical Safety Technologies | 87% | |
| Apella Technology | 85% | |
| Theator | 81% |
For institutional investors. Book with your work email.
Caresyntax Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Aug 15, 2024 | ||||
| Series C | Feb 14, 2024 | ||||
| Series C Extension | Sep 16, 2021 | ||||
| Series C | Apr 28, 2021 | ||||
| Series B | Dec 17, 2019 | ||||
Debt | Jul 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Caresyntax Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Norgine Ventures | Debt |
| Novacap | Series C Extension |
| IPF Partners | Debt, Series C Extension, Series C, Series B |
| Plug and Play Tech Center | Debt, Series B |
| Almak Capital | Series B |
| Cure Capital Advisors | Debt |
| Lauxera Capital Partners | Debt, Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 76% MoM, reaching 13.7K.
- Oct 25, 2025
Launched Clinical Data as a Service (CDaaS) for healthcare and life sciences.
For institutional investors. Book with your work email.
Caresyntax Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Caresyntax's valuation, stock price, and market status.
Is Caresyntax a public or private company?
Caresyntax is a private company.
What is the current stock price of Caresyntax?
Caresyntax is a private company, so its shares have no public market price. Caplight tracks Caresyntax's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Caresyntax worth (valuation)?
Valuation information for Caresyntax is not publicly available.
Can I buy Caresyntax stock?
Caresyntax shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Caresyntax's last funding round?
Caresyntax's most recent funding round was Debt on August 15, 2024.
Who are the main investors in Caresyntax?
Key investors in Caresyntax include Norgine Ventures, Novacap, IPF Partners, Lauxera Capital Partners, MTIP.
Will Caresyntax IPO soon?
No public IPO plans have been announced for Caresyntax.
How can I track Caresyntax secondary market activity?
Caplight tracks bids, offers, and trades in Caresyntax's shares on secondary markets.